Evidence map›Paper›PMID 38951175›Full record

ArticleJournal of neurology2024

Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson's disease: cross-sectional and longitudinal evidence from the LANDSCAPE study.

Anja Ophey, Kathrin Wirtz, Steffen Wolfsgruber, Monika Balzer-Geldsetzer, Daniela Berg, Rüdiger Hilker-Roggendorf, Jan Kassubek, Inga Liepelt-Scarfone, Sara Becker, Britt Mollenhauer and 10 more

Abstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Anja OpheyDepartment of Medical Psychology | Neuropsychology and Gender Studies, Center for Neuropsychological Diagnostic and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. anja.ophey@uk-koeln.de.ORCID http://orcid.org/0000-0001-5858-7762
Kathrin WirtzDepartment of Medical Psychology | Neuropsychology and Gender Studies, Center for Neuropsychological Diagnostic and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Steffen WolfsgruberGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Monika Balzer-GeldsetzerEthikkommission, Ludwig-Maximilians-Universität München, München, Germany.
Daniela BergDepartment of Neurology, University Medical Center Schleswig-Holstein, Christian Albrechts-University (CAU), Campus Kiel, Kiel, Germany.ORCID http://orcid.org/0000-0001-5796-5442
Rüdiger Hilker-RoggendorfDepartment of Neurology, Klinikum Vest, Recklinghausen, Germany.
Jan KassubekDepartment of Neurology, University Hospital Ulm, Ulm, Germany.ORCID http://orcid.org/0000-0002-7106-9270
Inga Liepelt-ScarfoneDepartment of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-0875-892X
Sara BeckerDepartment of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.ORCID http://orcid.org/0000-0002-4595-580X
Britt MollenhauerParacelsus-Elena Klinik, Kassel, Germany.
Kathrin ReetzDepartment of Neurology, RWTH Aachen University Hospital, Aachen, Germany.ORCID http://orcid.org/0000-0002-9730-9228
Oliver RiedelDepartment Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology-BIPS, Bremen, Germany.ORCID http://orcid.org/0000-0002-1721-502X
Jörg B SchulzDepartment of Neurology, RWTH Aachen University Hospital, Aachen, Germany.ORCID http://orcid.org/0000-0002-8903-0593
Alexander StorchDepartment of Neurology, University of Rostock and German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, Germany.ORCID http://orcid.org/0000-0002-1133-9216
Claudia TrenkwalderParacelsus-Elena Klinik, Kassel, Germany.
Karsten WittDepartment of Neurology, School of Medicine and Health Sciences and Research Center Neurosensory Science, University of Oldenburg, Oldenburg, Germany.
Hans-Ullrich WittchenDepartment of Psychiatry and Psychotherapy, University Hospital Munich, Ludwig-Maximilians-University Munich, Munich, Germany.
Richard DodelDepartment of Geriatric Medicine, University Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0000-0003-2044-6299
Sandra Roeske *German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID http://orcid.org/0000-0002-8262-4356
Elke Kalbe *Department of Medical Psychology | Neuropsychology and Gender Studies, Center for Neuropsychological Diagnostic and Intervention (CeNDI), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.ORCID http://orcid.org/0000-0001-8603-2545

Funding

Bundesministerium für Bildung und Forschung 01GI1008C
6 · The paper itself

Abstract

backgroundCognitive reserve (CR) is considered a protective factor for cognitive function and may explain interindividual differences of cognitive performance given similar levels of neurodegeneration, e.g., in Alzheimer´s disease. Recent evidence suggests that CR is also relevant in Parkinson's disease (PD).

objectiveWe aimed to explore the role of life-stage specific CR for overall cognition and specific cognitive domains cross-sectionally and longitudinally in PD.

methodsThe cross-sectional analysis with data from the DEMPARK/LANDSCAPE study included 81 individuals without cognitive impairment (PD-N) and 87 individuals with mild cognitive impairment (PD-MCI). Longitudinal data covered 4 years with over 500 observations. CR was operationalized with the Lifetime of Experiences Questionnaire (LEQ), capturing the complexity of lifestyle activities across distinct life-stages. Cognition was assessed using a comprehensive neuropsychological test battery.

resultsHigher LEQ scores, particularly from mid- and late-life, were observed in PD-N compared to PD-MCI [F(1,153) = 4.609, p = .033, η

conclusionsThis study emphasizes the association between complex lifestyle activities and cognition in PD. Data indicate that while CR might be related to a delay of cognitive decline, individuals with high CR may experience a more pronounced drop in overall cognition and memory. Future studies will have to replicate these findings, particularly regarding domain-specific effects and considering reverse causal mechanisms.

Indexed as

Cognitive DysfunctionCognitive ReserveLife StyleParkinson DiseaseAgedAged, 80 and overCross-Sectional StudiesFemaleHumansLongitudinal StudiesMaleMiddle AgedNeuropsychological TestsCognitive dysfunctionCognitive reserveLifestyleParkinson's disease

Identifiers

PMID38951175
PMCPMC11319368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.